1.  Estimated amount of contracts net of advances remaining to be
 executed on capital account Rs. 144,631 (''000s) [Previous Year Rs. 217,843
 (''000s)].
 
 2.  Contingent Liabilities
 
                                                         Rs. ''000s
 
 Particulars                                As at          As at
                                           March 31,      March 31,
                                            2011           2010
 
 (a) In respect of Bank Guarantees issued 
 in favour of statutory authorities         4,986          7,945
 
 (b) Counter Guarantee by the Company 
 issued in favour of Gujarat Industrial
  Development                               2,967          2,967
 Corporation
 
 (c) In respect of customs duty on 
 outstanding Export obligation against
 advance licenses                         123,765        171,981 
 acquired by the Company
 
 (d) Claims against the Company not 
 acknowledged as debts in respect of
 litigation/ claims                        32,889         17,559
 filed by customer/ vendor/ labour
 
 (e) In respect of Indirect Tax matters 
 (Excise duty, Customs duty, Service tax
  and Sales tax)                          753,559        736,545
 
 (f) In respect of Direct Tax matters     170,901        168,895
 
 (g) Demand raised by Ministry of 
 Chemicals and Fertilisers, Department 
 of Chemicals and Petro                    27,581         27,581
 Chemicals for the difference between the 
 pooled price and the retention price on 
 the production of Chloroquine Phosphate 
 from 1979-1980 upto December 14,1988. 
 
 The Company has filed a writ petition in the Hon''able High Court of
 Mumbai, challenging this demand.
 
 Note: Future cash flows in respect of (d) to (g) above, if any, is
 determinable only on receipt of judgement/ decisions pending with
 relevant authorities.
 
 3.  Operating Lease
 
 a) Assets taken on lease:
 
 The Company has taken residential flats and office under
 non-cancellable operating lease and lease rent amounting to Rs. 31,631
 (''000s) [Previous Year f 44,008 (''000s)] has been debited to Profit and
 Loss Account.
 
 4.  Segment Reporting
 
 The Company has only one reportable business segment Agri Care as
 primary segment. The Company has identified the Secondary Segment as
 geographical segment based on the location of customers.
 
 5.  Related Party Transactions (as identified by the Management) (i)
 Ultimate Holding Company : Bayer AG, Germany (ii) Parties under common
 control :
 
 - Bayer (China) Limited, China
 
 - Bayer (Malaysia) Sdn. Bhd., Malaysia
 
 - Bayer A/S, Denmark
 
 - Bayer Animal Health GmbH, Germany
 
 - Bayer Australia Limited, Australia
 
 - Bayer BioScience Private Limited, India
 
 - Bayer Business and Technology Services LLC, U.S.A.
 
 - Bayer Business Services GmbH, Germany
 
 - Bayer Business Services Private Limited, India (from December 1,
 2010)
 
 - Bayer CropScience (China) Co. Limited, China
 
 - Bayer CropScience (Pvt.) Limited, Pakistan
 
 - Bayer CropScience AG, Germany
 
 - Bayer CropScience K.K., Japan
 
 - Bayer CropScience Limited, Bangladesh
 
 - Bayer CropScience Limited, Korea
 
 - Bayer CropScience OHQ (Malaysia) Sdn. Bhd., Malaysia
 
 - Bayer CropScience Pty Limited, Australia
 
 - Bayer CropScience S.A., France (upto December 31, 2009)
 
 - Bayer CropScience Inc., U.S.A.
 
 - Bayer Direct Services GmbH, Germany
 
 - Bayer Health Care AG, Germany
 
 - Bayer HealthCare Aktiengesellschaft, Germany
 
 - Bayer HealthCare LLC, U.S.A.
 
 - Bayer HealthCare Limited, Hongkong
 
 - Bayer HealthCare Pharmaceuticals Inc., U.S.A.
 
 - Bayer Industry Services GmbH, Germany
 
 - Bayer Korea Limited, Korea
 
 - Bayer Malibu Polymers Private Limited, India
 
 - Bayer MaterialScience AG, Germany
 
 - Bayer MaterialScience Limited, Hongkong
 
 - Bayer MaterialScience Private Limited, India
 
 - Bayer Middle East FZE, U.A.E.
 
 - Bayer New Zealand Limited, New Zealand
 
 - Bayer Parsian AG, Iran
 
 - Bayer Pharmaceuticals Private Limited, India
 
 - Bayer Public Limited Company, United Kingdom
 
 - Bayer S.A., Brazil
 
 - Bayer S.A.S., France (from January 1, 2010)
 
 - Bayer South East Asia Pte Limited, Singapore
 
 - Bayer Taiwan Company Limited, Taiwan
 
 - Bayer Technology and Engineering (Shanghai) Co. Limited, China
 
 - Bayer Technology Services, Germany
 
 - Bayer Thai Company Limited, Thailand
 
 - Bayer Turk Kimya Sanayi Limited Sti., Turkey
 
 - Bayer Vietnam Limited, Vietnam
 
 - Bayer Yakuhin Limited, Japan
 
 - Bilag Industries Private Limited, India
 
 - EuroServices Bayer GmbH, Germany
 
 - Nunhems Seeds Private Limited, India
 
 - PT Bayer Indonesia, Indonesia (iii) Key Management Personnel:
 
 Mr.  Stephan Gerlich Vice Chairman and Managing Director
 
 Mr.  Kaikobad B. Mistry Whole-time Director
 
 6.  Employee Benefits
 
 The disclosures required as per Accounting Standard 15 - Employee
 Benefits (revised 2005) are as under:
 
 a) Brief description of the Plans:
 
 The Company has various schemes for employee benefits such as provident
 fund, superannuation, gratuity, pension and long service award. In case
 of funded schemes, the funds are administered through trustees/
 appropriate authorities. The Company''s defined contribution plans are
 superannuation and provident fund since the Company has no further
 obligation beyond making the contributions. The Company''s defined
 benefit plans include gratuity and pension. The employees of the
 Company are entitled to leave encashment, compensated absences and long
 service award as per the Company''s policy.
 
 7. The amount of excise duty disclosed as deduction from turnover is
 the total excise duty for the year except the excise duty related to
 the difference between the closing stock and opening stock and excise
 duty paid but not recovered, which has been disclosed as excise duty
 expense in the Schedule 19.
 
 8.  The Bayer Companies worldwide place great importance on protecting
 the environment and conserving natural resources. Pursuant to the
 cessation of manufacturing activities at Thane, till date the Company
 has incurred Rs. 37,785 (''000s) during the year 2010-11 [Previous Year Rs.
 54,904 (''000s)] towards Demolition and Remediation activities. These
 ongoing activities will allow the Thane Site to be left in a safe state
 with human health and environmental risks mitigated to generally
 accepted levels in industrialised countries.
 
 9.  The Company has entered into a non-binding and exclusive
 arrangement with Agile Real Estate Private Limited (AREPL) vide
 Memorandum of Understanding (MOU) dated March 31, 2011 for the
 proposed sale of Land and Buildings situated at Village Balkum, Thane
 at a consideration to be finalised at a future date. The net book value
 of the Land and Buildings as on March 31, 2011 is Rs. 915,389 (''000s) and
 Rs. 128,716 (''000s), respectively.
 
 The Company has received an earnest amount of Rs. 2,600,000 (''000s) for
 this exclusive arrangement, which is disclosed under the head Current
 Liabilities. The conveyance, transfer, sale and possession of the
 aforesaid Thane Land and Buildings will be completed at a future date
 subject to relevant approvals, permissions from the government and
 other statutory bodies, as may be deemed necessary and on receipt of
 sale consideration on or before September 30, 2012.
 
 10.  Previous year figures have been re-grouped/ re-classified wherever
 necessary.